Bridgewater Associates’s Usana Health Sciences USNA Stock Holding History

Bridgewater Associates’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-35,668	Closed	-$2.25M	–	813
2023 Q2	$2.25M	Sell	35,668 -13,634	-28%	-$868K	0.01%	443
2023 Q1	$3.1M	Buy	49,302 +25,513	+107%	+$1.52M	0.02%	388
2022 Q4	$1.27M	Sell	23,789 -7,610	-24%	-$412K	0.01%	615
2022 Q3	$1.76M	Sell	31,399 -855	-3%	-$56.5K	0.01%	589
2022 Q2	$2.33M	Buy	32,254 +1,222	+4%	+$91K	0.01%	647
2022 Q1	$2.46M	Buy	31,032 +6,753	+28%	+$609K	0.01%	628
2021 Q4	$2.46M	Sell	24,279 -10,756	-31%	-$1.07M	0.01%	432
2021 Q3	$3.23M	Sell	35,035 -1,495	-4%	-$144K	0.02%	358
2021 Q2	$3.74M	Buy	+36,530	New	+$3.67M	0.02%	382

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Bridgewater Associates's USNA Position: Q3 2023 in Review

Bridgewater Associates sold out of Usana Health Sciences (USNA) in Q3 2023, closing a stake of 35,668 shares — an estimated $2.25M sold.

Bridgewater Associates first reported a position in USNA in Q2 2021 and held it in 9 quarters. The position peaked at $3.74M in Q2 2021. 160 funds tracked by Wall St. Rank hold USNA as of Q3 2023.

Bridgewater Associates reported no remaining Usana Health Sciences position as of Q3 2023 after selling out during the quarter.
Bridgewater Associates sold 35,668 Usana Health Sciences shares in Q3 2023, an estimated $2.25M.
Bridgewater Associates first reported a position in Usana Health Sciences in Q2 2021 and held it in 9 quarters.
Bridgewater Associates's Usana Health Sciences position peaked at $3.74M in Q2 2021.
160 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2023.

Based on Bridgewater Associates's 13F filing for Q3 2023, filed 13 Nov 2023.